Anthony Evnin
Partner Emeritus
Description:
Anthony Evnin, Ph.D. has served as a director since March 2002. He has been a Partner at Venrock, where he has focused largely on life sciences investments and, in particular, biotechnology investments, since 1975. Evnin currently serves on the boards of Infinity Pharmaceuticals, Inc. and Pharmos Corporation as well as a number of private companies, including Acceleron Pharma Inc. and Metabolex, Inc. Evnin is a Trustee of The Rockefeller University, a Trustee of The Jackson Laboratory, a Trustee Emeritus of Princeton University, and a Member of the Boards of Overseers and Managers of Memorial Sloan-Kettering Cancer Center. Evnin holds a Ph.D. in Chemistry from the Massachusetts Institute of Technology and an A.B. from Princeton University.
Summary:
Anthony Evnin, Ph.D. has served as a director since March 2002. He has been a Partner at Venrock, where he has focused largely on life scie...
Number of Registered Investments:1
Contact Details:
- Address: New York, New York, United States
- No email is provided
Location:New York, New York, United States
Email is Not Provided
Phone Number:New York, New York, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 